Unknown

Dataset Information

0

Neurocognitive phenotype of isolated methylmalonic acidemia.


ABSTRACT: OBJECTIVE:Methylmalonic acidemia (MMA) is a metabolic disorder with a poorly defined long-term neurocognitive phenotype. We studied the neuropsychological outcomes of patients and examined clinical covariates that influenced cognition. METHODS:A diverse cohort with mut, cblA, or cblB subtypes of isolated MMA (N = 43), ages 2 to 32 years, were evaluated at a single center over a 6-year period. The influence of clinical, laboratory, and metabolic parameters on neuropsychological testing results was determined. RESULTS:Early-onset mut patients (n = 21) manifested the most severe neurocognitive impairments, with a mean ± SD full-scale IQ (FSIQ) of 71.1 ± 14.75. Late-onset mut patients (n = 6) had a mean FSIQ of 88.5 ± 27.62. cblA (n = 7), cblB (n = 6), and mut patients diagnosed prenatally or by newborn screening (n = 3) obtained mean FSIQs in the average range (100.7 ± 10.95, 96.6 ± 10.92, and 106.7 ± 6.66, respectively). Hyperammonemia at diagnosis and the presence of a seizure disorder were associated with a lower FSIQ (P = .001 and P = .041, respectively), but other clinical variables, including basal ganglia injury and mutation status, did not. FSIQ remained stable over longitudinal testing (n = 10). Decreased scores on processing speed, compared with all other intellectual domains, emerged as a specific neurocognitive manifestation. CONCLUSIONS:The neurocognitive outcomes seen in isolated MMA are highly variable. An earlier age of disease onset, the presence of hyperammonemia at diagnosis, and a history of seizures were associated with more severe impairment. In all patient subtypes, selective deficits in processing speed were present.

SUBMITTER: O'Shea CJ 

PROVIDER: S-EPMC3362903 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>Methylmalonic acidemia (MMA) is a metabolic disorder with a poorly defined long-term neurocognitive phenotype. We studied the neuropsychological outcomes of patients and examined clinical covariates that influenced cognition.<h4>Methods</h4>A diverse cohort with mut, cblA, or cblB subtypes of isolated MMA (N = 43), ages 2 to 32 years, were evaluated at a single center over a 6-year period. The influence of clinical, laboratory, and metabolic parameters on neuropsychological tes  ...[more]

Similar Datasets

| S-EPMC4149057 | biostudies-literature
| S-EPMC7965933 | biostudies-literature
| S-EPMC10918191 | biostudies-literature
| S-EPMC9464863 | biostudies-literature
| S-EPMC8283478 | biostudies-literature
| S-EPMC2140053 | biostudies-literature
| S-EPMC2660647 | biostudies-literature
| S-EPMC5214677 | biostudies-literature
2019-08-01 | GSE118862 | GEO
| S-EPMC5660767 | biostudies-literature